108 related articles for article (PubMed ID: 33788709)
1. Understanding the Biological Basis of Glioblastoma Patient-derived Spheroids.
Turnovcova K; Marekova D; Sursal T; Krupova M; Gandhi R; Krupa P; Kaiser R; Herynek V; Netuka D; Jendelova P; Jhanwar-Uniyal M
Anticancer Res; 2021 Mar; 41(3):1183-1195. PubMed ID: 33788709
[TBL] [Abstract][Full Text] [Related]
2. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
4. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitivity of Patient-Derived Glioma Stem Cell 3-Dimensional Cultures to Photon, Proton, and Carbon Irradiation.
Chiblak S; Tang Z; Campos B; Gal Z; Unterberg A; Debus J; Herold-Mende C; Abdollahi A
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):112-119. PubMed ID: 26254681
[TBL] [Abstract][Full Text] [Related]
6. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
Jensen SS; Petterson SA; Halle B; Aaberg-Jessen C; Kristensen BW
BMC Cancer; 2017 Mar; 17(1):178. PubMed ID: 28270132
[TBL] [Abstract][Full Text] [Related]
7. shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.
Haynes HR; Scott HL; Killick-Cole CL; Shaw G; Brend T; Hares KM; Redondo J; Kemp KC; Ballesteros LS; Herman A; Cordero-Llana O; Singleton WG; Mills F; Batstone T; Bulstrode H; Kauppinen RA; Wurdak H; Uney JB; Short SC; Wilkins A; Kurian KM
J Pathol; 2019 Apr; 247(4):422-434. PubMed ID: 30565681
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
9. Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model.
Jensen SS; Meyer M; Petterson SA; Halle B; Rosager AM; Aaberg-Jessen C; Thomassen M; Burton M; Kruse TA; Kristensen BW
PLoS One; 2016; 11(7):e0159746. PubMed ID: 27454178
[TBL] [Abstract][Full Text] [Related]
10. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells.
Chakrabarti M; Ray SK
Brain Res; 2015 Dec; 1629():85-93. PubMed ID: 26471408
[TBL] [Abstract][Full Text] [Related]
12. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.
Munthe S; Sørensen MD; Thomassen M; Burton M; Kruse TA; Lathia JD; Poulsen FR; Kristensen BW
J Neurooncol; 2016 Oct; 130(1):53-62. PubMed ID: 27510953
[TBL] [Abstract][Full Text] [Related]
13. 2D and 3D
Hira VV; Breznik B; Van Noorden CJ; Lah T; Molenaar RJ
Biotechniques; 2020 Nov; 69(5):339-346. PubMed ID: 32867513
[TBL] [Abstract][Full Text] [Related]
14. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells.
Jiang X; Yan Y; Hu M; Chen X; Wang Y; Dai Y; Wu D; Wang Y; Zhuang Z; Xia H
J Neurosurg; 2016 Jan; 124(1):129-36. PubMed ID: 26274999
[TBL] [Abstract][Full Text] [Related]
15. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.
Marfia G; Campanella R; Navone SE; Di Vito C; Riccitelli E; Hadi LA; Bornati A; de Rezende G; Giussani P; Tringali C; Viani P; Rampini P; Alessandri G; Parati E; Riboni L
Glia; 2014 Dec; 62(12):1968-81. PubMed ID: 25042636
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
17. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
[TBL] [Abstract][Full Text] [Related]
18. Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma.
Skaga E; Kulesskiy E; Fayzullin A; Sandberg CJ; Potdar S; Kyttälä A; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO
BMC Cancer; 2019 Jun; 19(1):628. PubMed ID: 31238897
[TBL] [Abstract][Full Text] [Related]
19. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
[TBL] [Abstract][Full Text] [Related]
20. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
